Ironwood Pharmaceuticals, Inc. IRWD
Set alert
3.46 USD -0.04 -1.14%
At close
3.21 -0.25 -7.23%
Pre-market · Nov 3, 5:09 AM ET
3.43 Day range 3.59
1.76 52-week range 5.78
- YTD
- +2.67%
- 1 year
- +86.02%
- Open
- 3.50
- Prev close
- 3.50
- Mkt cap
- 571.73M
- Vol
- 1.30M
- Avg vol
- 1.96M
- EPS
- 0.76
- P/E
- 4.55
- Div yield
- 0.00%
More statistics
- Low
- 3.43
- High
- 3.59
- Forward P/E
- 12.08
- Beta
- 0.47
- Short ratio
- 6.73
- Inst. own
- 105.29%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.98
- 200-d avg
- 5.77
- 1y target
- 12.50
News
-
2 weeks ago benzinga.com
Ironwood Pharmaceuticals Appoints Tammi Gaskins CEO, Effective Jan. 1, 2027
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today…
4 weeks ago benzinga.com
Ironwood Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is…